243 related articles for article (PubMed ID: 1735147)
1. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.
Cody RJ; Haas GJ; Binkley PF; Capers Q; Kelley R
Circulation; 1992 Feb; 85(2):504-9. PubMed ID: 1735147
[TBL] [Abstract][Full Text] [Related]
2. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure.
Tsutamoto T; Wada A; Maeda Y; Adachi T; Kinoshita M
J Am Coll Cardiol; 1994 May; 23(6):1427-33. PubMed ID: 8176102
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma concentrations of endothelin in congestive heart failure in humans.
Rodeheffer RJ; Lerman A; Heublein DM; Burnett JC
Mayo Clin Proc; 1992 Aug; 67(8):719-24. PubMed ID: 1434909
[TBL] [Abstract][Full Text] [Related]
4. Plasma endothelin levels and surgically correctable pulmonary hypertension.
Chang H; Wu GJ; Wang SM; Hung CR
Ann Thorac Surg; 1993 Feb; 55(2):450-8. PubMed ID: 8431058
[TBL] [Abstract][Full Text] [Related]
5. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
[TBL] [Abstract][Full Text] [Related]
6. Plasma endothelin-1 in acute myocardial infarction with heart failure.
Tomoda H
Am Heart J; 1993 Mar; 125(3):667-72. PubMed ID: 8438694
[TBL] [Abstract][Full Text] [Related]
7. The potential role of endothelin as a vasoconstrictor substance in congestive heart failure.
Cody RJ
Eur Heart J; 1992 Nov; 13(11):1573-8. PubMed ID: 1464346
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
Stewart DJ; Levy RD; Cernacek P; Langleben D
Ann Intern Med; 1991 Mar; 114(6):464-9. PubMed ID: 1994793
[TBL] [Abstract][Full Text] [Related]
9. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.
Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O
Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874
[TBL] [Abstract][Full Text] [Related]
10. The dynamic change of plasma endothelin-1 during the perioperative period in patients with rheumatic valvular disease and secondary pulmonary hypertension.
Zhu ZG; Wang MS; Jiang ZB; Jiang Z; Xu SX; Ren CY; Shi MX
J Thorac Cardiovasc Surg; 1994 Nov; 108(5):960-8. PubMed ID: 7967681
[TBL] [Abstract][Full Text] [Related]
11. Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease.
Filep JG; Bodolay E; Sipka S; Gyimesi E; Csipö I; Szegedi G
Circulation; 1995 Nov; 92(10):2969-74. PubMed ID: 7586267
[TBL] [Abstract][Full Text] [Related]
12. [Level of endothelin increases in chronic congestive heart failure].
Halawa B
Kardiol Pol; 1993 Mar; 38(3):169-72; discussion 173. PubMed ID: 8230990
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.
Sakai S; Miyauchi T; Sakurai T; Yamaguchi I; Kobayashi M; Goto K; Sugishita Y
J Am Coll Cardiol; 1996 Nov; 28(6):1580-8. PubMed ID: 8917275
[TBL] [Abstract][Full Text] [Related]
14. Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension.
Staniloae C; Dupuis J; White M; Gosselin G; Dyrda I; Bois M; Crépeau J; Bonan R; Caron A; Lavoie J
J Card Fail; 2004 Oct; 10(5):427-32. PubMed ID: 15470654
[TBL] [Abstract][Full Text] [Related]
15. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension.
Pacher R; Bergler-Klein J; Globits S; Teufelsbauer H; Schuller M; Krauter A; Ogris E; Rödler S; Wutte M; Hartter E
Am J Cardiol; 1993 Jun; 71(15):1293-9. PubMed ID: 8498369
[TBL] [Abstract][Full Text] [Related]
16. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
17. Increased endothelin in experimental heart failure.
Margulies KB; Hildebrand FL; Lerman A; Perrella MA; Burnett JC
Circulation; 1990 Dec; 82(6):2226-30. PubMed ID: 2242543
[TBL] [Abstract][Full Text] [Related]
18. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels.
Nootens M; Kaufmann E; Rector T; Toher C; Judd D; Francis GS; Rich S
J Am Coll Cardiol; 1995 Dec; 26(7):1581-5. PubMed ID: 7594089
[TBL] [Abstract][Full Text] [Related]
19. Plasma endothelin in congestive heart failure: a predictor of cardiac death?
Galatius-Jensen S; Wroblewski H; Emmeluth C; Bie P; Haunsø S; Kastrup J
J Card Fail; 1996 Jun; 2(2):71-6. PubMed ID: 8798108
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock.
Cernacek P; Stewart DJ
Biochem Biophys Res Commun; 1989 Jun; 161(2):562-7. PubMed ID: 2660789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
